BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · Real-Time Price · USD

1.840

+0.310 (20.26%)

At close: Jun 6, 2025, 4:00 PM

1.800

-0.040 (-2.17%)

After-hours: Jun 6, 2025, 7:20 PM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $11.14 million as of June 6, 2025. Its market cap has decreased by -85.23% in one year.

Market Cap

11.14M

Enterprise Value

86.01M

1-Year Change

-85.23%

Ranking

#5095

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $11.14M, a decrease of -93.54%. That is a compound annual growth rate of -31.46%.

Market Cap History

Date	Market Cap	% Change
Jun 6, 2025	11.14M	-39.95%
Dec 31, 2024	18.56M	-78.51%
Dec 29, 2023	86.35M	-85.65%
Dec 30, 2022	601.94M	5.82%
Dec 31, 2021	568.84M	-49.47%
Dec 31, 2020	1.13B	327.27%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	690.90B
Johnson & Johnson	374.75B
AbbVie	335.60B
Novo Nordisk	324.15B
UnitedHealth Group	272.60B
Abbott Laboratories	234.82B
Novartis AG	230.96B
AstraZeneca	225.55B

Market Cap Rankings